Unexpectedly, there was a decreasing trend in glucose levels in Aurkaf/+;VillinCre/+ mice (Figure 2M), suggesting that Aurka loss in the intestinal epithelium could influence metabolism, thus contributing to obesity rather than glucose tolerance. Here, AURKA is linked to obesity due to melanocortin 4 receptor deficiency.